Collectively, these results indicate that circRAPGEF1 competes with ASS1 mRNA for binding to IGF2BP3, resulting in the destabilization of ASS1 mRNA and subsequent downregulation of ASS1 expression in HCC cells. Here, ASS1 is linked to hepatocellular carcinoma.